ANKRD55 and myeloid sarcoma: Our work now links ANKRD55 MS risk SNPs already associated with a constitutive regulatory cis effect on ANKRD55 and IL6ST gene expression in CD4+ T cells now to a distinct regulatory element mediating an opposite IL-4/GM-CSF-induced cis effect in monocytes.